Effectiveness of 6-lead consumer-grade ECG monitoring on the detection of newly diagnosed arrhythmias in patients taking proarrhythmic medications: an interim analysis

14 April 2026 (08:00 - 14:45)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Miss Sujeong Eom

VUNO Inc., Seoul (Korea (Republic of))

188 More presentations in this session

Presentation thumbnail

Comparison of ECG findings between young patients with cryptogenic ischemic stroke and stroke-free control subjects

Doctor J. Uutela (Jyvaskyla, FI)

Presentation thumbnail

A wearable SCG-based approach for early, low-cost screening of valvular heart disease

Doctor V. Pergola (Naples, IT)

Presentation thumbnail

Intraoperative assessment of cardiac parasympathetic tone using short-term HRV metrics before and after atropine administration: a pilot study

Doctor B. Hrymniak (Wroclaw, PL)

Presentation thumbnail

Arrhythmia phenotypes in hair-loss therapies: insights from minoxidil and finasteride reports in eudravigilance

Doctor Y. Shhab (Bucharest, RO)

Presentation thumbnail

Arrhythmias and device therapy in HFpEF: Insights from a real-world hospital cohort

Ms A. Bondoc (Timisoara, RO)

Abstract Slides Video

Access the full session

Session thumbnail

Poster session (3): mechanisms and management of arrhythmias

The Event

Event poster

EHRA 2026

14 April 2026 08:00 CET

You may be interested in

Congress Presentation

Evaluation of ambulatory electrocardiographic monitoring of patients after high-risk acute coronary syndrome. A randomized trial.

Congress Presentation

Beyond atrial fibrillation screening: characterizing other clinically relevant arrhythmias detected during 14-day electrocardiogram monitoring.

Congress Presentation

Unveiling the superiority of 6-lead consumer-grade ECG: a comparative study on arrhythmia detection and numerical accuracy

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources